- Home
- OZ vs ZYXI Comparison
OZ vs ZYXI Comparison
Compare OZ & ZYXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OZ
- ZYXI
- Stock Information
- Founded
- OZ 2020
- ZYXI 1996
- Country
- OZ United States
- ZYXI United States
- Employees
- OZ N/A
- ZYXI N/A
- Industry
- OZ
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- OZ
- ZYXI Health Care
- Exchange
- OZ Nasdaq
- ZYXI Nasdaq
- Market Cap
- OZ 254.2M
- ZYXI 257.1M
- IPO Year
- OZ N/A
- ZYXI N/A
- Fundamental
- Price
- OZ $64.00
- ZYXI $7.71
- Analyst Decision
- OZ
- ZYXI Strong Buy
- Analyst Count
- OZ 0
- ZYXI 2
- Target Price
- OZ N/A
- ZYXI $13.50
- AVG Volume (30 Days)
- OZ 4.8K
- ZYXI 98.5K
- Earning Date
- OZ 01-01-0001
- ZYXI 10-24-2024
- Dividend Yield
- OZ N/A
- ZYXI N/A
- EPS Growth
- OZ N/A
- ZYXI N/A
- EPS
- OZ N/A
- ZYXI 0.18
- Revenue
- OZ $1,700,000.00
- ZYXI $193,614,000.00
- Revenue This Year
- OZ N/A
- ZYXI $11.68
- Revenue Next Year
- OZ N/A
- ZYXI $20.90
- P/E Ratio
- OZ N/A
- ZYXI $42.70
- Revenue Growth
- OZ N/A
- ZYXI 9.11
- 52 Week Low
- OZ $42.75
- ZYXI $7.04
- 52 Week High
- OZ $82.95
- ZYXI $13.77
- Technical
- Relative Strength Index (RSI)
- OZ 35.56
- ZYXI 42.26
- Support Level
- OZ $69.01
- ZYXI $7.61
- Resistance Level
- OZ $70.76
- ZYXI $7.99
- Average True Range (ATR)
- OZ 0.96
- ZYXI 0.28
- MACD
- OZ -0.87
- ZYXI -0.03
- Stochastic Oscillator
- OZ 0.00
- ZYXI 11.63
About OZ Belpointe PREP LLC Units
Belpointe PREP LLC is a qualified opportunity fund. The company's investments consist of properties located in qualified opportunity zones for the development or redevelopment of multifamily, student housing, senior living, healthcare, industrial, self-storage, hospitality, office, mixed-use, data centers, and solar projects located throughout the United States and its territories.
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.